How we’re different.
Genomics is awash in thousands of companies doing important but very similar work. Biofidelity is different.
We believe in the power of simple.
At Biofidelity, we’re working towards a future where more people around the world have access to the life-changing power of genomics. Our novel molecular technologies simplify genomic analysis, so more patients have access to the information needed to ensure the best possible outcomes.
Our vision doesn’t end with oncology, though. Our revolutionary technologies will pave the way for tomorrow’s yet-unknown scientific breakthroughs.
At Biofidelity, we believe in the transformational power of genomics. We believe that with imagination and ingenuity, anything is possible. Most importantly, when it comes to humanity’s most complex problems, we believe in the power of simple.
Our mission is to remove the noise from genomics with revolutionary technologies that will save lives around the world.
01
Revolutionary Technologies
Genuinely unique technologies that make genomic analysis simpler, faster, and more adaptable.
02
Purpose-Built Solutions
Solutions designed to extract actionable insights from existing genomics tools.
03
A Decentralized Approach
The power to perform localized genomics and make groundbreaking discoveries.
Our Leadership Team
Barnaby Balmforth, PhD
Chief Executive Officer
Catherine Jean Potgieter
Vice President of People
Jonathan Senior, MD
Chief Financial Officer
Kelly R. Pitts, PhD
Chief Operating Officer
Lee Anderson
Chief Commercial Officer
Wendy J. Levin, MD, MS
Chief Medical Officer
Our Board of Directors
Barnaby Balmforth, PhD
Chief Executive Officer
Heiner Dreismann
Chairman
Ciarán O’Leary
Director
Matthew Frohn
Director
Matt Franklin
Director
Our Scientific Advisory Board
Mace Rothenberg, MD
Hesham A. Abdullah, MD, MS
Jerald Radich, MD
Lee Newcomer, MD
Join our team.
Build a career that’s engaging, supportive, and inspiring. Join us at the forefront of efforts to create a world where everyone has access to the life-changing power of genomics.